Urology · Nashville, TN
NPI
1265669683
Since 2009
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2801 Charlotte Ave
Nashville, TN, 37209
Phone (615) 250-9200
Groups this clinician bills Medicare through
Medicare paid, 2024
$961K
22,361 services
Medicare patients, 2024
591
Average age 74
Drug cost, 2024
$8.2M
1,764 prescriptions
Company payments, 2025
$242K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gautam Jayram was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 5,525 times for 53 patients. In total Gautam Jayram billed 22,361 services in 119 codes, and Medicare paid $961K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,525 | 53 | $0.11 | $585 |
| J0897 Injection, denosumab, 1 mg | Office | 3,360 | 19 | $20.40 | $69K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,700 | 11 | $2.24 | $3,815 |
| 99214 Office E&M - Established | Office | 960 | 502 | $80.23 | $77K |
| 84153 Clinical Chemistry | Office | 594 | 327 | $17.88 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 541 | 363 | $11.95 | $6,467 |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 462 | 11 | $46.27 | $21K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 346 | 48 | $140.00 | $48K |
| 84403 Clinical Chemistry | Office | 313 | 145 | $24.92 | $7,799 |
| 81001 Clinical Chemistry | Office | 266 | 179 | $3.10 | $824 |
| 81003 Clinical Chemistry | Office | 239 | 178 | $2.15 | $513 |
| 51798 Ultrasound - Nonspecific | Office | 239 | 163 | $7.00 | $1,673 |
| 99213 Office E&M - Established | Office | 110 | 86 | $63.87 | $7,026 |
| 36415 Venipuncture Blood Collection | Office | 108 | 104 | $8.42 | $910 |
| 96402 Chemotherapy Administration | Office | 84 | 59 | $21.14 | $1,775 |
By year: 2022 $1.0M for 32,670 services; 2023 $764K for 23,811 services; 2024 $961K for 22,361 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84153 Clinical Chemistry | 594 | 327 | $17.88 | $11K |
| 84403 Clinical Chemistry | 313 | 145 | $24.92 | $7,799 |
| 81001 Clinical Chemistry | 266 | 179 | $3.10 | $824 |
| 81003 Clinical Chemistry | 239 | 178 | $2.15 | $513 |
| 36415 Venipuncture Blood Collection | 108 | 104 | $8.42 | $910 |
| 87086 Bacterial Culture | 51 | 39 | $7.91 | $403 |
| 80048 Clinical Chemistry | 45 | 41 | $7.96 | $358 |
| 80053 Clinical Chemistry | 42 | 35 | $10.35 | $435 |
| 84154 Clinical Chemistry | 41 | 37 | $18.02 | $739 |
| 85025 Blood Count | 37 | 31 | $7.61 | $282 |
Medicare prescription drug claims, 2024
In 2024, the drug Gautam Jayram prescribed most often to Medicare patients was Erleada (Apalutamide), with 328 prescriptions and refills. In total Gautam Jayram wrote 1,764 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erleada Apalutamide | 328 | 328 | 50 | $4.7M |
| Tamsulosin Hcl Generic | 290 | 655 | 93 | $3,845 |
| Orgovyx Relugolix | 196 | 197 | 38 | $506K |
| Xtandi Enzalutamide | 151 | 152 | 23 | $2.0M |
| Prednisone Generic | 138 | 148 | 22 | $607 |
| Abiraterone Acetate Generic | 137 | 141 | 19 | $288K |
| Levofloxacin Generic | 68 | 68 | 58 | $198 |
| Myrbetriq Mirabegron | 48 | 62 | Under 11 | $27K |
| Nubeqa Darolutamide | 44 | 44 | Under 11 | $587K |
| Ciprofloxacin Hcl Generic | 43 | 43 | 36 | $224 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 36 | 49 | 23 | $419 |
| Finasteride Generic | 34 | 94 | 14 | $553 |
| Testosterone Cypionate Generic | 31 | 63 | Under 11 | $1,887 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 22 | 22 | 22 | $314 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 19 | 19 | 16 | $205 |
Brand drugs: - claims; generic drugs: 961 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gautam Jayram $242K ($242K in general payments such as food, travel and fees) from 31 companies. The largest payer was Ferring Pharmaceuticals Inc. with $90K.
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 68 | $90K |
| Janssen Biotech, Inc. JNJ | 49 | $38K |
| AstraZeneca Pharmaceuticals LP AZN | 23 | $26K |
| Merck Sharp & Dohme LLC MRK | 25 | $17K |
| Immunitybio, Inc. IBRX | 12 | $15K |
| Photocure Inc | 4 | $11K |
| Urogen Pharma, Inc. URGN | 11 | $8,347 |
| KARL STORZ Endoscopy-America | 3 | $8,138 |
| Pfizer Inc. PFE | 15 | $7,800 |
| Telix Pharmaceuticals TLX | 8 | $6,743 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.